LOCALLY ADVANCED UROTHELIAL CARCINOMA
Clinical trials for LOCALLY ADVANCED UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested in Tough-to-Treat bladder cancer
Disease control Recruiting nowThis early-stage study is testing a combination of two drugs, cabozantinib and enfortumab vedotin, for advanced bladder cancer that has spread. The main goal is to find the safest and most effective dose. The study will also look for early signs that the treatment can shrink tumo…
Matched conditions: LOCALLY ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New Two-Drug attack tested for Tough-to-Treat bladder cancer
Disease control Recruiting nowThis study is for people with advanced bladder cancer that has spread and has stopped responding to a common type of immunotherapy. It compares a new two-drug combination (pembrolizumab and sacituzumab govitecan) against standard chemotherapy. The goal is to see if the new combin…
Matched conditions: LOCALLY ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New attack plan for tough bladder cancer: hit it with drugs, then zap or cut it out
Disease control Recruiting nowThis study is for people with advanced bladder cancer that has spread to a few other spots in the body. It tests if adding surgery or radiation to remove the main tumor and its spread, after initial drug therapy has controlled the cancer, can help keep the cancer from growing bac…
Matched conditions: LOCALLY ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Custom-Made vaccine aims to train immune system to fight advanced cancers
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to target the unique proteins on a patient's own cancer cells. It is being given alongside an existing immunotherapy drug (pembrolizumab) to see if the combination is safe and can help control advanced solid tumors that h…
Matched conditions: LOCALLY ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Cancer care comes home: mayo clinic tests At-Home immunotherapy shots
Disease control Recruiting nowThis study is testing whether giving a cancer immunotherapy treatment called nivolumab as an injection at home is a safe and practical alternative to receiving it at a clinic. It aims to see if home treatment reduces the burden of travel and improves quality of life for patients …
Matched conditions: LOCALLY ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC